LUCENT-1 (NCT 03518086)
ELU-4-58F581-1

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENTĀ 1)


Primary Purpose
Lilly Lucent imaging in Ulcerative Colitis
Study Types
C71104
Description of Cohorts
Lucent
Informed Consent Given?
True
Multi-center Study?
-
Organisms
Homo sapiens
Number of subjects
430
Diseases
Ulcerative Colitis
Sample Sources
Tissue Sample
Type of Samples Collected
Tissue